Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
This study has been completed.
Study NCT00346853   Information provided by University of Utah
First Received: June 28, 2006   Last Updated: July 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Dystrophy, Corneal
Additional conditions recognized in this trial
Corneal Dystrophies, Hereditary
More general conditions related to this trial
Corneal Diseases
Eye Diseases
Eye Diseases, Hereditary
Genetic Diseases, Inborn
Interventions listed in this trial
4-Methylpyrazole
saline
Additional drug interventions recognized in this trial
Fomepizole
More general drug interventions related to this trial
Antidotes
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
University of Utah


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services